Nothing Special   »   [go: up one dir, main page]
create a website
Intangibles Kapital und Rentabilität in der Pharmaindustrie. (2011). Mahlich, Jorg C ; Yurtoglu, Burcin.
In: Die Unternehmung - Swiss Journal of Business Research and Practice.
RePEc:nms:untern:10.5771/0042-059x-2011-1-32.

Full description at Econpapers || Download paper

Cited: 1

Citations received by this document

Cites: 56

References cited by this document

Cocites: 38

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. Capitalizing research & development and ‘other information’: the incremental information content of accruals versus cash flows. (2011). Schultze, Wolfgang ; DinhThi, Tami .
    In: Metrika: International Journal for Theoretical and Applied Statistics.
    RePEc:spr:metrik:v:22:y:2011:i:3:p:241-278.

    Full description at Econpapers || Download paper

References

References cited by this document

  1. Achleitner, A.-K/Behr, G. (2000): International Accounting Standards, München.
    Paper not yet in RePEc: Add citation now
  2. Adams, C.P./Brantner, Van V. (2006): Estimating the cost of new drug development: is it really 802 million dollars?, in: Health Affairs, Jg. 25, S. 420-428.
    Paper not yet in RePEc: Add citation now

  3. Alderson, M.J./Betker, B.L. (1996): Liquidation Costs and Accounting Data, in: Financial Management, Jg. 25, S. 25–36.

  4. Angell, M. (2004): The Truth About the Drug Companies: How They Deceive Us and What To Do About It, New York.
    Paper not yet in RePEc: Add citation now

  5. Aoki, M. (1990): Toward an Economic Model of the Japanese Firm, in: Journal of Economic Literature, Jg. 28, S. 1-27.

  6. Ayanian, R. (1975): Advertising and Rate of Return, in: Journal of Law and Economics, Jg. 18, S. 479-506.

  7. Baily, M.N. (1972): Research and Development Costs and Returns: The U.S. Pharmaceutical Industry, in: Journal of Political Economy, Jg. 80, S. 70-85.

  8. Bain, J.S. (1956): Barriers to New Competition, Cambridge.
    Paper not yet in RePEc: Add citation now

  9. Bloch, H. (1974): Advertising and Profitability: A Reappraisal, in: Journal of Political Economy, Jg. 82, S. 267-286.

  10. Brainard, W./Tobin, J. (1968): Pitfalls in financial model building’, in: American Economic Review, Jg. 8, Nr. 2, S. 99-122.

  11. Broda, B. (2003): Alternative Ansätze zur Messung des intellektuellen Kapitals, in: Der Schweizer Treuhänder, Nr. 09, S. 729-740.
    Paper not yet in RePEc: Add citation now
  12. Brooking, A. (1996), Intellectual Capital: Core Asset for the New Millennium, London.
    Paper not yet in RePEc: Add citation now

  13. Chung, K.H./Pruitt, S.W. (1994): A simple approximation of Tobins q, in: Financial Management, Jg. 23, S. 70–74.

  14. Clarkson, K. W. (1977): Intangible Capital and Rates of Return, Washington.
    Paper not yet in RePEc: Add citation now

  15. Cockburn, I.M./Henderson, R.M. (2001): Scale and Scope in Drug Development: Unpacking the Advantage of Size in Pharmaceutical Research, in: Journal of Health Economics, Jg. 20, S. 10331057.

  16. Comanor, W.S./Wilson, T.A. (1967): Advertising, Market Structure and Performance, in: The Review of Economics and Statistics, Jg. 49, S. 423-440.
    Paper not yet in RePEc: Add citation now
  17. Die Weltwoche (2004): Im Wesen nichts Neues, Interview mit Marcia Angell, Ausgabe 37/04 vom 08.09.2004.
    Paper not yet in RePEc: Add citation now

  18. DiMasi, J.A./Hansen, R.W./Grabowski, H.G. (2003): The Price of Innovation: New Estimates of Drug Development Costs, in: Journal of Health Economics, Jg. 22, S. 151-185.

  19. Domowitz, I./Hubbard, G./Peterson, B. (1986): Business Cycles and the Relationship between PriceCost -Margins, in: Rand Journal of Economics, Jg. 17, S. 1-17.

  20. Edvinsson, L. (1997): Intellectual Capital, Stockholm.
    Paper not yet in RePEc: Add citation now
  21. Fortune (2010): FORTUNE 500: Our annual ranking of America’s largest corporations, unter: http:// money.cnn.com/magazines/fortune/fortune500_archive/full/1955/, abgerufen am 20.4.2010.
    Paper not yet in RePEc: Add citation now

  22. Grabowski H.G./Vernon, J. (2000): The determinants of pharmaceutical research and development expenditures, in: Journal of Evolutionary Economics, Jg. 10, S. 201-215.

  23. Grabowski, H.G./Mueller, D.C. (1978): Industrial Research and Development, Intangible Capital Stocks, and Firm Profit Rates, in: The Bell Journal of Economics, Jg. 9, S. 328-343.

  24. Grabowski, H.G./Vernon, J. (1990): A new look at the returns and risks to pharmaceutical R&D, in: Management Science, Jg. 36, Nr. 7, S. 804-821.

  25. Hall, B./Oriani, R. (2006): Does the Market Value R&D Investment by European Firms? Evidence from a Panel of Manufacturing Firms in France, Germany, and Italy, in: International Journal of Industrial Organization, Jg. 24, Nr. 5, S. 971-993.

  26. Henderson, R./Cockburn, I. (1996): Scale, scope and spillovers: the determinants of research and productivity in drug industry, in: RAND Journal of Economics, Jg. 27, S. 32-59.

  27. Informa Healthcare (2009): Scrip Pharmaceutical League Tables 2009, London.
    Paper not yet in RePEc: Add citation now
  28. Kaplan, R.S./Norton, D.P. (1992): The Balanced Scorecard- Measures that Drive Performance, in: Harvard Business Review, Jg. 70, S. 71-79.
    Paper not yet in RePEc: Add citation now
  29. Lev, B. (2001): Intangibles: Management, Measurement, and Reporting, Washington.
    Paper not yet in RePEc: Add citation now
  30. Lev, B. (2004): Sharpening the Intangible Edge, in: Harvard Business Review, Jg. 82, S. 109-116.
    Paper not yet in RePEc: Add citation now

  31. Lev, B./Sarath, B./Sougiannis, T. (2005): R&D Reporting Biases and their Consequences, in: Contemporary Accounting Research, Jg. 22, S. 977-1026.

  32. Lewellen, G. Wilbur/Badrinath, S-G. (1997): On the Measurement of Tobins q, in: Journal of Financial Economics, Jg. 44, S. 77-122.

  33. Mahlich, J. (2005): Wirtschaftspolitik für wissensintensive Branchen am Beispiel der Pharmaindustrie, in: Zeitschrift für Wirtschaftspolitik, Jg. 54, S. 366-387.

  34. Mahlich, J. (2006): Anmerkungen zur Profitabilität der Pharmaindustrie, in: Wirtschaftswissenschaftliches Studium, Jg. 35, Nr. 2, S. 73-81.
    Paper not yet in RePEc: Add citation now

  35. Mahlich, J./Roediger-Schluga, T. (2006): Determinants of Pharmaceutical R&D: Evidence from Japan, in: Review of Industrial Organization, Jg. 28, S. 145-164.

  36. Mansfield, E. (1968): The Economics of Technological Change, New York.
    Paper not yet in RePEc: Add citation now
  37. Mayo, A. (2001): The Human Value of the Enterprise, London.
    Paper not yet in RePEc: Add citation now

  38. Megna, P./Mueller, D.C. (1991): Profit Rates and Intangible Capital, in: The Review of Economics and Statistics, Jg. 73, S. 632-642.

  39. Mueller, D.C. (1986): Profits in the Long Run, Cambridge.

  40. Mueller, D.C. (1990): The Dynamics of Company Profits, Cambridge.
    Paper not yet in RePEc: Add citation now

  41. Nadiri, M.I./Prucha, I.R. (1996): Estimation of the Depreciation Rate of Physical and R&D Capital in the U.S. Total Manufacturing Sector, in: Economic Inquiry, Jg. 34, Nr. 1, S. 43-56.

  42. Nerlove, M./Arrow, K.J. (1962): Optimal Advertising Policy under Dynamic Conditions, in: Econo mica, Jg. 29, S. 129-142.
    Paper not yet in RePEc: Add citation now
  43. Odagiri, H. (1992): Growth through Competition, Competition through Growth- Strategic Management and the Economy in Japan, Oxford.
    Paper not yet in RePEc: Add citation now

  44. Odagiri, H./Haneda, S. (1998): Appropriation of returns from technological assets and the values of patents and R&D in Japanese high-tech firms, in: Economics of Innovation and New Technology, Jg. 7, S. 303-321.

  45. Perfect, S./Wiles, K. (1994): Alternative Constructions of Tobins q: An Empirical Comparison, in: Journal of Empirical Finance, Jg. 1, S. 313–341.

  46. PhRMA (2006): Pharmaceutical Industry Profile 2006, Washington.
    Paper not yet in RePEc: Add citation now

  47. Porter, M.E. (1974): Consumer Behavior, Retailer Power and Market Performance in Consumer Goods Industries, in: The Review of Economics and Statistics, Jg. 56, S. 419-436.

  48. Salamon, G.L. (1982): Cash recovery rates and measures of firm profitability, in: Accounting Review, Jg. 57, Nr. 2, S. 292-302.
    Paper not yet in RePEc: Add citation now
  49. Salmi, T. (1982): Estimating the internal rate of return from published financial statements, in: Journal of Business Finance and Accounting, Jg. 9, Nr. 1, S. 63-74.
    Paper not yet in RePEc: Add citation now
  50. Schäppi, H. (2002): Es ist an der Zeit, wieder radikal zu werden – Rentabilität und gesellschaftliche Bedürfnisse in der Medizin, in: Bulletin von Medicus Mundi Schweiz, Jg. 84, April.
    Paper not yet in RePEc: Add citation now
  51. Scherer, F.M. (2001): The link between gross profitability and pharmaceutical R&D spending, in: Health Affairs, Jg. 20, Nr. 5, S. 216-220.
    Paper not yet in RePEc: Add citation now
  52. Schmalensee, R. (1972): The Economics of Advertising, Amsterdam.
    Paper not yet in RePEc: Add citation now

  53. Schmalensee, R. (1989): Inter-Industry Studies of Structure and Performance, in: Schmalensee, R./ Willig, R. (Hrsg.): Handbook of Industrial Organization, Amsterdam, North-Holland, S. 9511009.

  54. Steward, T.A. (1997): Intellectual capital - the new wealth of organizations, New York.
    Paper not yet in RePEc: Add citation now
  55. Sveiby, K.E. (1997): The New Organizational Wealth: Managing and Measuring Knowledge-Based Assets, San Francisco.
    Paper not yet in RePEc: Add citation now

  56. Taylor, C. (1999): The cash recovery method of calculating profitability: an application to pharmaceutical firms, in: Review of Industrial Organization, Jg. 14, S. 135-146.

Cocites

Documents in RePEc which have cited the same bibliography

  1. Working capital balances and financial policy. (2024). Oztekin, Ozde ; Flannery, Mark J.
    In: Journal of Corporate Finance.
    RePEc:eee:corfin:v:87:y:2024:i:c:s0929119924000804.

    Full description at Econpapers || Download paper

  2. Carbon pricing and enterprise productivity-The role of price stabilization mechanism. (2023). Wang, Jianing ; Tu, Qiang ; Mo, Jianlei.
    In: Energy Economics.
    RePEc:eee:eneeco:v:120:y:2023:i:c:s0140988323001299.

    Full description at Econpapers || Download paper

  3. Nature of financial constraints and R&D intensity. (2022). Banerjee, Pradip.
    In: Finance Research Letters.
    RePEc:eee:finlet:v:50:y:2022:i:c:s1544612322003907.

    Full description at Econpapers || Download paper

  4. Capital Structure Choices in Technology Firms: Empirical Results from Polish Listed Companies. (2020). Grabinski, Konrad ; Grabinska, Barbara ; Kedzior, Marcin.
    In: JRFM.
    RePEc:gam:jjrfmx:v:13:y:2020:i:9:p:221-:d:417252.

    Full description at Econpapers || Download paper

  5. Innovation activities of firms in Germany - Results of the German CIS 2012 and 2014: Background report on the surveys of the Mannheim Innovation Panel Conducted in the Years 2013 to 2016. (2017). Rammer, Christian ; Peters, Bettina ; Hud, Martin ; Hünermund, Paul ; Berger, Marius ; Iferd, Younes ; Hunermund, Paul ; Behrens, Vanessa ; Schubert, Torben.
    In: ZEW Dokumentationen.
    RePEc:zbw:zewdok:1704.

    Full description at Econpapers || Download paper

  6. Dynamic R&D choice and the impact of the firms financial strength. (2017). Roberts, Mark ; Peters, Bettina ; Vuong, Van Anh.
    In: Economics of Innovation and New Technology.
    RePEc:taf:ecinnt:v:26:y:2017:i:1-2:p:134-149.

    Full description at Econpapers || Download paper

  7. Corporate Postretirement Benefit Plans and Real Investment. (2017). Bartram, Söhnke.
    In: Management Science.
    RePEc:inm:ormnsc:v:63:y:2017:i:2:p:355-383.

    Full description at Econpapers || Download paper

  8. Seeking Finance, Perceived Financial Constraints and R&D Engagement. (2017). Lu, YU.
    In: Post-Print.
    RePEc:hal:journl:hal-02559421.

    Full description at Econpapers || Download paper

  9. Risk-shifting, equity risk, and the distress puzzle. (2017). Lockwood, Jimmy ; Miao, Hong ; Li, Keming.
    In: Journal of Corporate Finance.
    RePEc:eee:corfin:v:44:y:2017:i:c:p:275-288.

    Full description at Econpapers || Download paper

  10. Determinants of Financing Decisions in Innovative Firms: A Review on Theoretical Backgrounds and Empirical Evidence. (2016). Diaconu, Mihaela.
    In: Ovidius University Annals, Economic Sciences Series.
    RePEc:ovi:oviste:v:xvi:y:2016:i:2:p:198-203.

    Full description at Econpapers || Download paper

  11. Dynamic R&D Choice and the Impact of the Firms Financial Strength. (2016). Roberts, Mark ; Peters, Bettina ; Vuong, Van Anh.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:22035.

    Full description at Econpapers || Download paper

  12. Dynamic R&D Choice and the Impact of the Firms Financial Strength. (2016). Roberts, Mark ; Peters, Bettina ; Vuong, Van Anh.
    In: Working Paper Series in Economics and Institutions of Innovation.
    RePEc:hhs:cesisp:0440.

    Full description at Econpapers || Download paper

  13. Banker on board and innovative activity. (2016). Ghosh, Saibal.
    In: Journal of Business Research.
    RePEc:eee:jbrese:v:69:y:2016:i:10:p:4205-4214.

    Full description at Econpapers || Download paper

  14. A theory of rollover risk, sudden stops, and foreign reserves. (2016). Kondo, Illenin ; Hur, Sewon.
    In: Journal of International Economics.
    RePEc:eee:inecon:v:103:y:2016:i:c:p:44-63.

    Full description at Econpapers || Download paper

  15. Financial Constraints, Innovation Performance and Sectoral Disaggregation. (2016). Vahter, Priit ; Efthyvoulou, Georgios.
    In: Manchester School.
    RePEc:bla:manchs:v:84:y:2016:i:2:p:125-158.

    Full description at Econpapers || Download paper

  16. Dokumentation zur Innovationserhebung 2014: Innovationen mit Bezug zur Energiewende, Finanzierung von Innovationen. (2015). Rammer, Christian ; Peters, Bettina.
    In: ZEW Dokumentationen.
    RePEc:zbw:zewdok:1502.

    Full description at Econpapers || Download paper

  17. Dynamic R&D choice and the impact of the firms financial strength. (2015). Roberts, Mark ; Peters, Bettina ; Vuong, Van Anh.
    In: ZEW Discussion Papers.
    RePEc:zbw:zewdip:15083.

    Full description at Econpapers || Download paper

  18. R&D Intensity and Financing Decisions: Evidence from European Firms. (2015). Ben Rejeb, Aymen ; Elkemali, Taoufik .
    In: Economics Bulletin.
    RePEc:ebl:ecbull:eb-14-00651.

    Full description at Econpapers || Download paper

  19. R&D Intensity and Financing Decisions: Evidence from European Firms. (2013). Matoussi, Hamadi ; Ben Rejeb, Aymen ; Elkemali, Taoufik .
    In: MPRA Paper.
    RePEc:pra:mprapa:52059.

    Full description at Econpapers || Download paper

  20. The Oxford Handbook of Corporate Governance. (2013). wright, mike ; Siegel, Donald.
    In: OUP Catalogue.
    RePEc:oxp:obooks:9780199642007.

    Full description at Econpapers || Download paper

  21. Innovative capability and financing constraints for innovation: More money, more innovation?. (2012). Peters, Bettina ; Hottenrott, Hanna.
    In: ZEW Discussion Papers.
    RePEc:zbw:zewdip:09081r2.

    Full description at Econpapers || Download paper

  22. Financial Constraints, Innovation Performance and Sectoral Disaggregation. (2012). Vahter, Priit ; Efthyvoulou, Georgios.
    In: Working Papers.
    RePEc:shf:wpaper:2012030.

    Full description at Econpapers || Download paper

  23. Distress risk premia in expected stock and bond returns. (2012). Zhang, Andrew Jianzhong .
    In: Journal of Banking & Finance.
    RePEc:eee:jbfina:v:36:y:2012:i:1:p:225-238.

    Full description at Econpapers || Download paper

  24. Innovative capability and financing constraints for innovation: More money, more innovation?. (2011). Peters, Bettina ; Hottenrott, Hanna.
    In: ZEW Discussion Papers.
    RePEc:zbw:zewdip:09081r.

    Full description at Econpapers || Download paper

  25. Intangibles Kapital und Rentabilität in der Pharmaindustrie. (2011). Mahlich, Jorg C ; Yurtoglu, Burcin.
    In: Die Unternehmung - Swiss Journal of Business Research and Practice.
    RePEc:nms:untern:10.5771/0042-059x-2011-1-32.

    Full description at Econpapers || Download paper

  26. R&D investment and financing constraints of small and medium-sized firms. (2011). Hottenrott, Hanna ; Czarnitzki, Dirk.
    In: Small Business Economics.
    RePEc:kap:sbusec:v:36:y:2011:i:1:p:65-83.

    Full description at Econpapers || Download paper

  27. The Financing of R&D and Innovation. (2010). Hall, Bronwyn H ; Lerner, Josh.
    In: Handbook of the Economics of Innovation.
    RePEc:eee:haechp:v1_609.

    Full description at Econpapers || Download paper

  28. Underinvestment, capital structure and strategic debt restructuring. (2010). Pawlina, Grzegorz .
    In: Journal of Corporate Finance.
    RePEc:eee:corfin:v:16:y:2010:i:5:p:679-702.

    Full description at Econpapers || Download paper

  29. Innovative capability and financing constraints for innovation: More money, more innovation?. (2009). Peters, Bettina ; Hottenrott, Hanna.
    In: ZEW Discussion Papers.
    RePEc:zbw:zewdip:09081.

    Full description at Econpapers || Download paper

  30. The Financing of R&D and Innovation. (2009). Lerner, Josh ; Hall, Bronwyn.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:15325.

    Full description at Econpapers || Download paper

  31. Capital Project Analysis When Cash Flows Evolve as a Continuous Time Branching Process. (2009). Davidson, Ian ; Shinozawa, Yoshikatsu ; Tippett, Mark.
    In: Abacus.
    RePEc:bla:abacus:v:45:y:2009:i:1:p:44-65.

    Full description at Econpapers || Download paper

  32. R&D Investment and Financing Constraints of Small and Medium-Sized Firm. (2008). Hottenrott, Hanna ; Czarnitzki, Dirk ; Binz, Hanna L..
    In: ZEW Discussion Papers.
    RePEc:zbw:zewdip:7357.

    Full description at Econpapers || Download paper

  33. The financing decisions of innovative firms. (2008). Casson, Peter D. ; Nisar, Tahir M. ; Martin, Roderick.
    In: Research in International Business and Finance.
    RePEc:eee:riibaf:v:22:y:2008:i:2:p:208-221.

    Full description at Econpapers || Download paper

  34. The Financing of Research and Development. (2003). Hall, Bronwyn.
    In: Finance.
    RePEc:wpa:wuwpfi:0303003.

    Full description at Econpapers || Download paper

  35. A Real Options Approach to Bankruptcy Costs: Evidence from Failed Commercial Banks During the 1990s. (2002). Mason, Joseph R..
    In: Center for Financial Institutions Working Papers.
    RePEc:wop:pennin:02-20.

    Full description at Econpapers || Download paper

  36. The Financing of Research and Development. (2002). Hall, Bronwyn.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:8773.

    Full description at Econpapers || Download paper

  37. The Financing of Research and Development. (2002). Hall, Bronwyn.
    In: Department of Economics, Working Paper Series.
    RePEc:cdl:econwp:qt34c1c643.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-01-31 06:46:25 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.